IRIS
Del Re, Marzia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4
Totale 4
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 4
Totale 4
Salva come PNG Salva come JPEG
Città #
Rome 4
Totale 4
Salva come PNG Salva come JPEG
Nome #
Multidisciplinary management of HER2-positive breast cancer with brain metastases: An evidence-based pragmatic approach moving from pathophysiology to clinical data 2
The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapies 2
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC 2
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours 2
Pharmacological insights on novel oral selective estrogen receptor degraders in breast cancer 1
Comparison of Real-Time PCR and Droplet Digital PCR for the Determination of JAK2V617F Mutation in Ph'-Negative Myeloproliferative Neoplasms 1
Recurrent USP6 rearrangement in a subset of atypical myofibroblastic tumours of the soft tissues: low-grade myofibroblastic sarcoma or atypical/malignant nodular fasciitis? 1
Nicotine Metabolite Ratio in Smokers: A Real World Experience 1
CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients 1
Detection of BRAF and KRAS mutations in DNA released by tumors in peripheral blood by an advanced digital droplet PCR 1
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences 1
PLASMA/SALIVA AND GENOTYPIC/PHENOTYPIC DIFFERENCES OF NICOTINE METABOLITE RATIO 1
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib 1
nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives 1
Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors 1
AR-V7 and AR-FL expression is associated with clinical outcome: a translational study in patients with castrate resistant prostate cancer 1
Large−Scale Profiling of Extracellular Vesicles Identified miR−625−5p as a Novel Biomarker of Immunotherapy Response in Advanced Non−Small−Cell Lung Cancer Patients 1
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs 1
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer 1
DPYD c.1905+1G>A and c.2846 A>T and UGT1A1*28 allelic variants as predictors of toxicity: pharmacogenetic translational analysis from the phase III TRIBE study in metastatic colorectal cancer 1
Predicting Fluoropyrimidine-Related Toxicity: Turning Wish to Will, The Pamm-Eortc Position 1
Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation 1
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment 1
Impact of IVS14+1G>A and 2846A>T DPYD polymorphisms on toxicity outcome of patients treated with fluoropyrimidine-containing regimens 1
Diagnosis and treatment monitoring in breast cancer: how liquid biopsy can support patient management 1
Empower the potential of trastuzumab deruxtecan with novel combinations 1
EGFR signaling pathway as therapeutic target in human cancers 1
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards 1
A real-world application of liquid biopsy in metastatic colorectal cancer: The poseidon study 1
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients 1
Should CYP2D6 be genotyped when treating with tamoxifen? [Letter in reply] 1
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 1
Gene-network analysis predicts clinical response to immunotherapy in patients affected by NSCLC 1
Angiogenic inhibitors in gastric cancers and gastroesophageal junction carcinomas: A critical insight 1
Matching BRCA and prostate cancer in a public health system: Report of the Italian Society for Uro-Oncology (SIUrO) consensus project 1
ErbB in NSCLC as a molecular target: Current evidences and future directions 1
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report 1
Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer 1
Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients 1
Author's reply. The detection of AR-V7 in plasma-derived exosomal RNA strongly predicts resistance to hormonal therapy in metastatic prostate cancer patients 1
Cross-Linked Hyaluronic Acid as Tear Film Substitute 1
Monitoring of secondary drug resistance mutations in circulating tumor DNA of patients with advanced ALK positive NSCLC 1
Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer 1
Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab 1
Totale 48
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202548 0 0 0 45 3 0 0 0 0 0 0 0
Totale 48